SE9700983D0 - Stimulering, odling och preservation av pankreas- och andra celler - Google Patents

Stimulering, odling och preservation av pankreas- och andra celler

Info

Publication number
SE9700983D0
SE9700983D0 SE9700983A SE9700983A SE9700983D0 SE 9700983 D0 SE9700983 D0 SE 9700983D0 SE 9700983 A SE9700983 A SE 9700983A SE 9700983 A SE9700983 A SE 9700983A SE 9700983 D0 SE9700983 D0 SE 9700983D0
Authority
SE
Sweden
Prior art keywords
cells
cellulose derivative
stimulation
pancreatic
culture
Prior art date
Application number
SE9700983A
Other languages
English (en)
Swedish (sv)
Inventor
Per Maansson
Tomas Lundin
Original Assignee
Ascendia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascendia Ab filed Critical Ascendia Ab
Priority to SE9700983A priority Critical patent/SE9700983D0/xx
Publication of SE9700983D0 publication Critical patent/SE9700983D0/xx
Priority to PCT/SE1998/000475 priority patent/WO1998041617A1/en
Priority to JP54043798A priority patent/JP4237265B2/ja
Priority to AU64313/98A priority patent/AU6431398A/en
Priority to CA002283676A priority patent/CA2283676C/en
Priority to US09/381,650 priority patent/US6479283B1/en
Priority to DE69839393T priority patent/DE69839393T2/de
Priority to AT98909956T priority patent/ATE393214T1/de
Priority to EP98909956A priority patent/EP0975739B1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10Preservation of living parts
    • A01N1/12Chemical aspects of preservation
    • A01N1/122Preservation or perfusion media
    • A01N1/126Physiologically active agents, e.g. antioxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/50Soluble polymers, e.g. polyethyleneglycol [PEG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE9700983A 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler SE9700983D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9700983A SE9700983D0 (sv) 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler
PCT/SE1998/000475 WO1998041617A1 (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells
JP54043798A JP4237265B2 (ja) 1997-03-18 1998-03-16 膵臓およびその他の細胞の刺激、培養および保存
AU64313/98A AU6431398A (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells
CA002283676A CA2283676C (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells
US09/381,650 US6479283B1 (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic cells
DE69839393T DE69839393T2 (de) 1997-03-18 1998-03-16 Stimulierung, züchtung und erhalt pankreatischer und anderer zellen
AT98909956T ATE393214T1 (de) 1997-03-18 1998-03-16 Stimulierung, züchtung und erhalt pankreatischer und anderer zellen
EP98909956A EP0975739B1 (de) 1997-03-18 1998-03-16 Stimulierung, züchtung und erhalt pankreatischer und anderer zellen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700983A SE9700983D0 (sv) 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler

Publications (1)

Publication Number Publication Date
SE9700983D0 true SE9700983D0 (sv) 1997-03-18

Family

ID=20406207

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700983A SE9700983D0 (sv) 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler

Country Status (9)

Country Link
US (1) US6479283B1 (de)
EP (1) EP0975739B1 (de)
JP (1) JP4237265B2 (de)
AT (1) ATE393214T1 (de)
AU (1) AU6431398A (de)
CA (1) CA2283676C (de)
DE (1) DE69839393T2 (de)
SE (1) SE9700983D0 (de)
WO (1) WO1998041617A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8033401A (en) * 2000-06-28 2002-01-08 Ascendia Ab Dna/rna-embedding medium and method of use
US20040186180A1 (en) 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
EP2079476B1 (de) * 2006-10-20 2014-05-21 Dow Global Technologies LLC Verwendung hydroxypropylmethylcellulose zur vorbeugung oder behandlung des stoffwechselsyndroms
DK2162531T3 (en) * 2007-05-04 2019-04-23 Ascendia Ab METHOD AND METHOD FOR CULTIVATING OSTEOBLASTIC CELLS
US8932858B2 (en) * 2008-03-07 2015-01-13 Corning Incorporated Modified polysaccharide for cell culture and release
JP2013506681A (ja) 2009-10-02 2013-02-28 バクスター・インターナショナル・インコーポレイテッド 腎損傷の処置における使用のための造血幹細胞
CA2840192A1 (en) 2011-06-23 2012-12-27 The Children's Hospital Of Philadelphia Self-renewing endodermal progenitor lines generated from human pluripotent stem cells and methods of use thereof
EP2817014A2 (de) 2012-02-21 2014-12-31 Baxter International Inc Pharmazeutische zusammensetzung mit cd34+-zellen
EP3167911A1 (de) * 2015-11-10 2017-05-17 Oniris In si-hpmc-eingekapselte insulinerzeugende zellen zur behandlung von typ-1-diabetes
WO2025117683A1 (en) * 2023-11-29 2025-06-05 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Compositions and methods for chemical pancreatectomy for pancreas transplantation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038139A (en) * 1976-07-16 1977-07-26 G. D. Searle & Co., Limited Cell culture medium
US4104124A (en) * 1976-08-30 1978-08-01 Louisiana State University Foundation Process for the production of single cell protein and amino acids
DE2726313C3 (de) * 1977-06-10 1980-02-07 Battelle-Institut E.V., 6000 Frankfurt Verfahren zur in-vitro-Biosynthese von Hormonen, insbesondere von Insulin
US4330622A (en) * 1979-09-12 1982-05-18 Becton Dickinson & Co. Elimination of non-microbial turbidity in culture media
JPS56167624A (en) * 1980-05-29 1981-12-23 Toray Ind Inc Method of interferon production
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
DD282471A5 (de) * 1989-04-21 1990-09-12 Staatliches Inst Fuer Immunpra Verfahren zur kultivation von mikroorganismen
JPH03175973A (ja) * 1989-09-26 1991-07-31 Kirin Brewery Co Ltd 動物細胞培養用担体およびその製造法
DE4115722A1 (de) * 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen
IL102929A (en) * 1992-08-24 1996-11-14 Interpharm Lab Ltd Serum-free medium for mammalian cells
US5834308A (en) * 1994-04-28 1998-11-10 University Of Florida Research Foundation, Inc. In vitro growth of functional islets of Langerhans
US5587309A (en) * 1994-04-29 1996-12-24 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating proliferation and differentiation of human fetal pancreatic cells ex vivo

Also Published As

Publication number Publication date
JP4237265B2 (ja) 2009-03-11
CA2283676A1 (en) 1998-09-24
DE69839393D1 (de) 2008-06-05
CA2283676C (en) 2004-11-02
WO1998041617A1 (en) 1998-09-24
JP2001521377A (ja) 2001-11-06
EP0975739B1 (de) 2008-04-23
EP0975739A1 (de) 2000-02-02
AU6431398A (en) 1998-10-12
US6479283B1 (en) 2002-11-12
DE69839393T2 (de) 2009-06-04
ATE393214T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
Axelrod et al. Stimulation of C14-melatonin synthesis from C14-tryptophan by noradrenaline in rat pineal in organ culture
ATE204176T1 (de) Verwendung von insulinähnlichen wachstumsfaktoren und analogen zur behandlung von erkrankungen der sehnerven
SE9700983D0 (sv) Stimulering, odling och preservation av pankreas- och andra celler
DE69801517D1 (de) Verfahren zur verhinderung der verkalkung von aldehyd-fixierten bioprothesenmaterialien
ATE265191T1 (de) Herstellungsverfahren von gewebe zur implantation
JO1552B1 (en) New pyridizinamine derivatives
PL322015A1 (en) Derivatives of hydroxylamine useful as compounds enhancing production of accompanying molecular protein and ethod of obtaining them
DK356984D0 (da) Gangliosidderivater, praeparater indeholdende disse samt fremgangsmaader til fremstilling deraf
FR2540381B1 (fr) Procede pour stimuler la croissance des cellules; composition cosmetique, pharmaceutique et composition complementaire pour milieu de culture cellulaire appliquant ce procede
ATE249249T1 (de) Steriler komplex eines therapeutischen peptids an ein polysaccharid
ES483655A1 (es) Procedimiento para disminuir el consumo animal de calorias
MX7708E (es) Procedimiento mejorado para estimular el crecimiento de plantas
DE69605298D1 (de) Herstellung von formulierungen zur arzneiverabreichung mittels elektrotransport
DK230590A (da) Sproejte til brug ved kataraktkirurgi
GR1000719B (el) Μεθοδος παρασκευης της (s)-α-εθυλ-2-οξο-1-πυρρολιδινοακεταμιδης.
ATE254884T1 (de) Biologisch abbaubare vorrichtung
HUP9901418A2 (hu) Eljárás levobupivakain és analóg hatóanyagok racemizálására
NO972523L (no) Fremgangsmåte ved fremstilling av en suspensjon i vann av en celluloseeter, og törrblanding egnet for anvendelse ved fremstilling av suspensjonen
Desgranges et al. Beneficial use of fibroblast growth factor 2 and RGTA, a new family of heparan mimics, for endothelialization of PET prostheses
ATE23112T1 (de) Verwendung von 1-(p-isopropoxyethoxymethylphenoxy)-3-isopropylamino-propan-2-ol zur herstellung eines arzneimittels zur senkung des augeninnendrucks.
DE69902397D1 (de) Neues verfahren zur kryokonservierung von pflanzen
FR2600671B1 (fr) Procede de conservation cryogenique de substances et matieres organiques, notamment de cellules
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
FI930654A0 (fi) Loesligt aldc-derivat och anvaendning av detta
Clark et al. The effect of various growth-promoting substances on the reproduction of Lemna